Tech Company Financing Transactions
Respicardia Funding Round
Respicardia closed a $58.5 million funding round on 12/19/2017. Investors included ZOLL Medical and private investors.
Transaction Overview
Company Name
Announced On
12/19/2017
Transaction Type
Venture Equity
Amount
$58,500,000
Round
Undisclosed
Investors
ZOLL Medical (Lead Investor) (Jonathan Rennert)
Proceeds Purpose
Proceeds from the financing will be used to fund our U.S. commercialization efforts and support ongoing development of the system.
Company Information
Company Status
Acquired or Merged
Industry
Medical Devices & Instruments
Mailing Address
12400 Whitewater Dr. 150
Minnetonka, MN 55343
USA
Minnetonka, MN 55343
USA
Phone
Website
Email Address
Overview
Founded in 2006 and headquartered near Minneapolis, Minnesota, Respicardia is dedicated to improving the lives of heart failure patients by developing implantable therapies designed to improve respiratory rhythm management and cardiovascular health.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Peter Sommerness
Chief Financial Officer
Tim Hauch
Chief Marketing Officer
Collin Anderson
Chief Medical Officer
Robin Germany
VP - R & D
Todd Goblish
VP - Regulatory Affairs
Timothy Meyer
Browse more venture capital transactions:
Prev: 12/19/2017: UrbanStems venture capital transaction
Next: 12/20/2017: SendBird venture capital transaction
Share this article
About Database of VC Transactions
We do our best to report on tech company VC transactions. VC transactions reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs